← Back to Patent Explorer
US5059690A Expired / Lapsed US ⏱️ 0.0 years remaining

Purinyl tetrahydrofurans

Assignee: ER Squibb and Sons LLC
•
Filing: 1990-03-01
•
Granted: 1991-10-22
•
Expires: 2010-03-01
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Antiviral activity is exhibited by compounds having the formula <IMAGE> and pharmaceutically acceptable salts thereof wherein R1 is a purine or pyrimidine base or an analog thereof and R2 and R3 are independently hydrogen, -PO3H2 or <IMAGE> wherein X7 is hydrogen, alkyl, substituted alkyl or aryl.

Inventors

  • 👤 Robert Zahler
  • 👤 Joseph A. Tino

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-29 06:20
CPC Classifications
C; C07; C07D; C07D473/00; C07D405/00; C07D405/02; C07D405/04; C07F; C07F9/00; C07F9/02; C07F9/547; C07F9/6558; C07F9/65586; C07F9/6561; C07F9/65616

Claims Analysis

Total Claims: 14
Claim 1
Independent Claim 219 words
A compound having the formula ##STR76## and pharmaceutically acceptable salts thereof wherein R 1 is ##STR77## wherein X 1 is hydrogen, amino, ##STR78## --N═CHN(X 8 ) 2 X 2 is methyl, fluoro, chloro, bromo, iodo, hydroxy, or amino, X 3 is hydrogen, chloro, or O-X 8 , X 4 is amino, chloro, ##STR79## or --N═CHN(X 8 ) 2 X 5 is hydrogen, methyl, fluoro, chloro, bromo, iodo, hydroxy, or amino, R 2 and R 3 are independently hydrogen, --PO 3 H 2 , or ##STR80## the term "alkyl" refers to straight and branched chained groups of 1 to 10 carbons, the term "substituted alkyl" refers to alkyl groups having one or more substituents selected from the group consisting of halogen, amino, axiod, hydroxy, cyano, trialkylammonium (wherein each alkyl group has 1 to 6 carbons), alkoxy of 1 to 6 carbons, phenyl, substituted phenyl, and carboxy, and the term "substituted phenyl" refers to a phenyl substituted with one, two, or three groups selected from the group consisting of alkyl of 1 to 6 carbons, alkoxy of 1 to 6 carbons, halogen, trifluoromethyl, amino, alkylamino of 1 to 6 carbons, halogen, trifluoromethyl, amino, alkylamino of 1 to 6 carbons, dialkylamino (wherein each alkyl group has 1 to 6 carbons), nitro, cyano, alkanoyloxy of 2 to 11 carbons, carboxy, carbonyl, and hydroxy.
Claim 2
Dependent Claim 219 words
A compound having the formula ##STR76## and pharmaceutically acceptable salts thereof wherein R 1 is ##STR77## wherein X 1 is hydrogen, amino, ##STR78## --N═CHN(X 8 ) 2 X 2 is methyl, fluoro, chloro, bromo, iodo, hydroxy, or amino, X 3 is hydrogen, chloro, or O-X 8 , X 4 is amino, chloro, ##STR79## or --N═CHN(X 8 ) 2 X 5 is hydrogen, methyl, fluoro, chloro, bromo, iodo, hydroxy, or amino, R 2 and R 3 are independently hydrogen, --PO 3 H 2 , or ##STR80## the term "alkyl" refers to straight and branched chained groups of 1 to 10 carbons, the term "substituted alkyl" refers to alkyl groups having one or more substituents selected from the group consisting of halogen, amino, axiod, hydroxy, cyano, trialkylammonium (wherein each alkyl group has 1 to 6 carbons), alkoxy of 1 to 6 carbons, phenyl, substituted phenyl, and carboxy, and the term "substituted phenyl" refers to a phenyl substituted with one, two, or three groups selected from the group consisting of alkyl of 1 to 6 carbons, alkoxy of 1 to 6 carbons, halogen, trifluoromethyl, amino, alkylamino of 1 to 6 carbons, halogen, trifluoromethyl, amino, alkylamino of 1 to 6 carbons, dialkylamino (wherein each alkyl group has 1 to 6 carbons), nitro, cyano, alkanoyloxy of 2 to 11 carbons, carboxy, carbonyl, and hydroxy.
Claim 3
Dependent Claim 18 words
A compound in accordance with claim 1 wherein R 2 and R 3 are independently hydrogen or ##STR81##
Claim 4
Dependent Claim 22 words
A compound in accordance with claim 1 wherein R 2 and R 3 are independently hydrogen or --PO 3 H 2 .
Claim 5
Dependent Claim 15 words
A compound in accordance with claim 1 wherein R 2 and R 3 are hydrogen.
Claim 6
Dependent Claim 12 words
A compound in accordance with claim 1 wherein R 1 is ##STR82##
Claim 7
Dependent Claim 12 words
A compound in accordance with claim 5 wherein R 1 is ##STR83##
Claim 8
Dependent Claim 12 words
A compound in accordance with claim 5 wherein R 1 is ##STR84##
Claim 9
Dependent Claim 12 words
A compound in accordance with claim 5 wherein R 1 is ##STR85##
Claim 10
Dependent Claim 12 words
A compound in accordance with claim 5 wherein R 1 is ##STR86##
Claim 11
Dependent Claim 12 words
A compound in accordance with claim 6 wherein R 1 is ##STR87##
Claim 12
Dependent Claim 12 words
A compound in accordance with claim 7 wherein R 1 is ##STR88##
Claim 13
Dependent Claim 8 words
A compound in accordance with claim 1, [3S-(3α,4β,5α)]-2-Amino-1,9-dihydro-9-[tetrahydro-4,5-bis(hydroxymethyl)-3-furanyl]-6H-purin-6-one.
Claim 14
Dependent Claim 8 words
A compound in accordance with claim 1, [3S-(3α,4β,5α)]-9-[Tetrahydro-4,5-bis(hydroxymethyl)-3-furanyl]-9H-purin-6-amine.

References Cited (Backward Citations)

GB2021582A Cited
JPS5714679A Cited
US4788181A Cited
EP0285884A2 Cited
WO1988007532A1 Cited
US4855466A Cited
EP0335355A2 Cited
US4918075A Cited
EP0391411A2 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1994-10-21 1995-04-22 1995-10-22 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1998-10-21 1999-04-22 1999-10-22 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2002-10-21 2003-04-22 2003-10-22 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag